G-CSFR−/− macrophages demonstrated increased NOS2 expression and tumor killing ability, while the addition of G-CSF to wildtype (WT) macrophages led to decreased NOS2 activity and increased IL-10 production to promote a pro-tumorigenic phenotype. The gene discussed is CSF3R; the disease is neoplasm.